Joel Verter, Ph.D. Senior Vice President

View Biography Print this Section

Hsia J, Alderman E, Verter J, Rogers W, Thompson P, Howard B, Cobb F, Ouyang P, Tardif J, Higginson L, Bittner V, Barofsky I, Steffes M, Gordon D, Proschan M, Younes N, Waters D. Women's Angiogrpahic Vitamin and Estrogen trial: design and methods. Controlled Clinical Trials 2002; 23:708-727.

Waters D, Alderman E, Hsia J, Howard B, Cobb F, Rogers W, Ouyang P, Thompson P, Tardif J, Higginson L, Bittner V, Steffes M, Gordon D, Proschan M, Younes N, Verter J. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized clinical trial. JAMA 2002; 288:2432-2440.

Bauer C, Shankaran S, Bada H, Lester B, Wright L, Krause-Steinrauf H, Smeriglio V, Finnegan L, Maza P, Verter J. The Maternal Lifecycle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstetrics and Gynecology 2002; 186:487-495.

Shankaran S, Papile L, Wright L, Ehrenkranz R, Mele L, Lemons J, Korones S, Stevenson D, Donovan E, Stoll B, Fanaroff A, Oh W, Verter J. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure. Am J Obstetrics and Gynecology 2002; 187:171-177.

Lemons J, Bauer C, Oh W, Korones S, Papile L, Stoll B, Verter J, Temprosa M, Wright L, Ehrenkranz R, Fanaroff A, Stark A, Carlo W, Tyson J, Donovan E, Shankaran S, Stevenson D. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001; Jan;107:E1.

Pfeffer M, Domanski M, Verter J, Dunlap M, Flaker G, Gersh B, Hsia J, Goldberg A, Limacher M, Maggioni A, Rosenberg Y, Rouleau J, Warnica J, Wasserman A, Braunwald E. The continutation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial. American Heart Journal 2001; Sep;142:375-377.

Lester B, ElSohly M, WRight L, Smeriglio V, Verter J, Bauer C, Shankaran S, Bada H, Walls H, Huestis M, Finnegan L, Maza P. The Maternal Lifecycle Study: drug use by meconium toxicology and maternal self-support. Pediatrics 2001; Feb;107:309-317.

Stevenson D, Verter J, Fanaroff A, Oh W, Ehrenkranz R, Shankaran S, Donovan E, Wright L, Lemons J, Tyson J, Korones S, Bauer C, Stoll B, Papile L. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed 2000; 83:F182-185.

Vohr BR, Wright LL, Dusick A, Steichen JJ, Mele L, Verter JI. Neurodevelopmental and functional outcome of extremely low birth weight infants in the National Institute of Child Health and Human Development National Research Network, 1993-1994. J Ped 2000; 105:1216-1226.

Walsh-Sukys MC, Tyson JE, Wright LL, Bauer C, Korones S, Stevenson D, Verter JI, Stoll B, Lemons J, Papile L, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. J Ped 2000; 105(1pt1):14-20.

Stoll B, Temprosa M, Tyson J, Papile L, Wright LL, Bauer C, Donovan E, Korones S, Lemons J, Fanaroff A, Stevenson D, Oh W, Ehrenkranz R, Shankaran S, Verter JI. Dexamethasone therapy increases infection in very low birth weight infants. J Ped 1999; 104(5):e63.

Donovan E, Tyson J, Ehrenkranz R, Verter J, Wright J, Wright LL, Korones S, Bauer C, Shankaran S, Stoll B, Fanaroff A, Oh W, Lemons J, Stevenson D, Papile L. Inaccuracy of Ballard scores before 28 weeks' gestation. J Ped 1999; 135:147-152.

Tyson J, Wright L, Oh W, Kennedy K, Mele L, Ehrenkranz R, Stoll B, Lemons J, Stevenson K, Bauer C, Korones D, Fanaroff A, Verter J. Vitamin A supplementation for extremely-low-birth-weight infants. N Eng J Med 1999; 340:1962-1968.

Stevenson D, Verter J. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Nework, January 1993 - December 1994. American Journal of Obstetrics and Gynecology 1998; 179 (6 Pt 1):1632-1639.

Bada H, Bauer C, Shankaran S, Lester B, Wright L, Verter J, Smeriglio V, Finnegan L, Maza P. Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates. Annals of the New York Academy of Sciences 1998; 846:431-434.

Papile LA, Tyson JE, Stoll B, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones S, Lemons J, Fanaroff AA. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Eng J Med 1998; 338(16):1112-1118.

Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, Tyson JE, Phillips JB III, Edwards W, Lucey JF, Catz CS, Shankaran S, Oh W. The incidence, presenting features, risk factors and significance of septicemia in low birth weight infants. J Inf Dis 1998; 17(7):593-598.

Pfeffer M, Domanski M, Rosenberg Y, Verter J, Geller N, Albert P, Hsia J, Braunwald E. Prevention of Events with Angiotensin-Converting Enzyme inhibition (The PEACE study design). Am J Cardiol 1998; 25H-30H.

Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in the term and near-term with hypoxic respiratory failure. N Engl J Med 1997; 336:597-604.

Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. J Pediatr 1997; 99:838-845.

Kennedy KA, Stoll B, Ehrenkranz R, Oh W, Wright LL, Stevenson DK, Lemons JA, Sowell A, Mele L, Tyson JE, Verter J. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? Early Human Development 1997; 49:19-31.

Shankaran S, Papile LA, Wright LL, Ehrenkranz RA, Mele L, Lemons JA, Korones SB, Stevenson DK, Donovan EF, Stoll BJ, Fanaroff AA, Oh W, Verter J. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Eng J Med 1997; 337:466-471.

Kennedy KA, Stoll BJ, Ehrenkranz RA, Oh W, Wright LL, Stevenson DK, Lemons JA, Verter J, Sowell A, Mele L, Tyson JE. Vitamin A to prevent bronchopulmonary dysplasia in ver-low-birthweight infants: has the dose been too low? Early Human Development 1997; 49:19-31.

Vreman HJ, Verter J, Oh W, Fanaroff A, Wright L, Lemons J, Shankaran S, Tyson J, Korones S, Bauer C, Stoll B, Papile L, Donovan E, Ehrenkranz R, Stevenson D. Variability of interlaboratory bilirubin measurements. Clin Chem 1996; 42(6):869-873.

Tyson J, Younes N, Verter J, Wright L. Viability, severe morbidity and resource use among newborns 501-800 g birth weight. Journal of American Medical Association 1996; 276(20):1645-1651.

Bjornson A, Falletta J, Verter J, Buchanan G, Miller S, Pegelow C, Iyer R, Johnstone H, DeBaun M, Wethers D, Wang W, Woods G, Holbrook R, Becton D, Kinney T, Reaman G, Kalinyak K, Grossman N, Vichinsky E, Reid C. Serotype-specific IgG antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Ped 1996; 129(6):828-835.

Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C, Fanaroff A, Lemons J, Donovan E, Oh W, Stevenson D, Ehrenkranz R, Papile L, Verter J, Wright L. Early-onset sepsis in very low birthweight neonates: A report from the NICHD Neonatal Research Network. J Ped 1996; 129:72-80.

Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C, Fanaroff A, Lemons J, Donovan E, Oh W, Stevenson D, Ehrenkranz R, Papile L, Verter J, Wright L. Late-onset sepsis in very low birthweight neonates: A report from the NICHD Neonatal Research Network. J Ped 1996; 129(1):

Falletta J, Woods G, Verter J, Buchanan G, Pegelow C, Iyer R, Miller S, Holbrook T, Kinney T, Vichinsky E, Becton D, Wang W, Johnstone H, Wethers D, Reaman G, DeBaun M, Grossman N, Kalinyak K, Jorgensen J, Bjornson A, Thomas M, Reid C. Discontinuing penicillin prophylaxis in children with sickle cell anemia. The J Ped 1995; 127(5):685-690.

Fanaroff A, Wright L, Stevenson D, Shankaran S, Donovan E, Ehrenkranz R, Younes N, Korones S, Stoll B, Tyson J, Bauer C, Oh W, Lemons J, Papile L, Verter J. Very-low-birthweight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. American Journal of Obstetrics and Gynecology 1995; 173:1423-1431.

Wright L, Verter J, Younes N, Stevenson D, Fanaroff A, Shankaran S, Ehrenkranz R, Donovan E. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD Neonatal Research Network. American Journal of Obstetrics and Gynecology 1995; 173:269-274.

Wright L, Horbar J, Gunkel H, Verter J, Younes N, Andrews E, Long W. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. American Journal of Obstetrics and Gynecology 1995; 173:263-269.

Ben-Menachem T, Fogel R, Patel R, Touchette M, Zarowitz B, Hadzijahic N, Divine G, Verter J, Bersalier R. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Annals of Internal Medicine 1994; 121:568-575.

Stevenson DK, Vreman HJ, Oh W, Fanaroff A, Wright L, Lemons J, Verter J, Shankaran S, Tyson J, Korones S, Bauer C, Stoll B, Papile L, Okah F, Ehrenkranz R. Bilirubin production in well term infants as measured by breath carbon monoxide. Clin Chem 1994; 40:1934-1939.

Friedman L, Bristow J, Hallstrom A, Schron E, Proschan M, Verter J, DeMets D, Fisch C, Nies A, Ruskin J, Strauss H, Walters L. Data monitoring in the cardiac arrhythmias suppression trial. Online Journal of Current Clinical Trials. 1993; 79:

Johnstone D, Verter JI, et al. Clinical characteristics of patients with severe left ventricular dysfunction: baseline results in studies of left ventricular dysfunction (SOLVD). Am J Cardio 1992;

The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685-691.

Investigators TCASTI. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327:227-233.

The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD) - rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990; 66:315-322.

Hallstrom AP, Verter JI, Friedman L. Randomizing responders. Control Clin Trials 1991; 12:486-503.

Gaston MH, Verter JI. The sickle cell anemia trial. Stat Med 1990; 9(1/2):45-54.

The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD) - rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990; 66:315-322.

Verter J. How much data should we collect in a randomized clinical trial? Stat Med 1990; 9(1/2):103-114.

Verter J. How much data should we collect in a randomized clinical trial? Stat Med 1990; 9(1/2):103-114.